PETROVA PENKA (Chief Development Officer) sold 2.60K shares of TRILLIUM THERAPEUTICS INC. on the open market
Open‑market sale worth $40.4K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/12/2021ACC: 0001062993-21-000289
Officer· Chief Development Officer
Since Jan 2021
-2.60K
Net shares
Net seller
$40.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.60K acquired · 5.21K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+2.60K
Price / share
$3.33
Trade value
$8.67K
% of position
New position
1/8/2021
0.00→2.60K
Common Shares
Direct
Shares
−2.60K
Price / share
$15.50
Trade value
$40.36K
% of position
New position
1/8/2021
2.60K→0.00
Total
Net shares
+0.00
Net value
-$31.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/8/2021 | M · Option Exercise | +2.60K | $3.33 | $8.67K | New position | 0.00 | 2.60K |
| Common Shares Direct | 1/8/2021 | S · Sale | −2.60K | $15.50 | $40.36K | New position | 2.60K | 0.00 |
| Total | +0.00 | -$31.69K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
2.60K shares
Shares
−2.60K
Strike price
3.3310
Held after
57.29K
Exercisable
—
1/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares2.60K shares | 1/8/2021 | M · Option Exercise | −2.60K | 3.3310 | — | 57.29K |